Clinical Trial Update: Prazosin for Treatment of Patients With Alcohol Dependence (AD) and Post Traumatic Stress Disorder (PTSD). [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating prazosin for alcohol dependence with comorbid PTSD completed; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence
• Post-traumatic Stress Disorder

Drugs mentioned

• Prazosin (prazosin)

Snippet

Sponsor: Yale University | Conditions: Alcohol Dependence, Stress Disorders, Post-Traumatic | Phase 3 | Status: COMPLETED | Results posted: 2016-01-18